Rona Jeffrey A bought OVID
February 26, 2026 · Form 4 insider transaction
Rona Jeffrey A bought 408,750 shares of Ovid Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
408,750
Price
$0.00
Total value
N/A
InsiderRona Jeffrey A
RoleOfficer
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 26, 2026
Filing dateMarch 2, 2026
Shares owned after408,750
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the stock option will vest in 48 equal monthly installments commencing on March 20, 2026, subject to the Reporting Person's continued services through each such date.